SCUTERI, Damiana
 Distribuzione geografica
Continente #
NA - Nord America 1.693
AS - Asia 1.623
EU - Europa 851
SA - Sud America 390
AF - Africa 105
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.669
Nazione #
US - Stati Uniti d'America 1.612
SG - Singapore 800
CN - Cina 339
BR - Brasile 283
IT - Italia 265
VN - Vietnam 211
UA - Ucraina 152
DE - Germania 122
AT - Austria 78
SN - Senegal 76
HK - Hong Kong 58
FI - Finlandia 56
SE - Svezia 48
CA - Canada 45
KR - Corea 42
AR - Argentina 38
IN - India 32
GB - Regno Unito 28
FR - Francia 23
MX - Messico 23
TR - Turchia 22
EC - Ecuador 21
JP - Giappone 21
BD - Bangladesh 19
RU - Federazione Russa 17
ID - Indonesia 14
CO - Colombia 13
CZ - Repubblica Ceca 12
IQ - Iraq 11
NL - Olanda 11
PK - Pakistan 11
ZA - Sudafrica 10
CL - Cile 9
AE - Emirati Arabi Uniti 7
PY - Paraguay 7
VE - Venezuela 7
LT - Lituania 6
MA - Marocco 6
TN - Tunisia 6
AU - Australia 5
BE - Belgio 5
BO - Bolivia 5
UZ - Uzbekistan 5
CH - Svizzera 4
CR - Costa Rica 4
ES - Italia 4
JO - Giordania 4
PL - Polonia 4
UY - Uruguay 4
AL - Albania 3
GR - Grecia 3
PE - Perù 3
PS - Palestinian Territory 3
BH - Bahrain 2
EG - Egitto 2
GE - Georgia 2
IE - Irlanda 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
SV - El Salvador 2
AM - Armenia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
PH - Filippine 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.669
Città #
Singapore 320
Chandler 279
Boardman 151
Dallas 121
Beijing 94
Jacksonville 88
Ho Chi Minh City 84
New York 82
San Mateo 82
Ashburn 79
Dakar 76
Vienna 60
Hong Kong 57
Helsinki 54
Hefei 43
Shanghai 42
Seoul 39
Hanoi 37
Lawrence 36
Roxbury 36
Rende 32
Dearborn 31
São Paulo 30
Brooklyn 27
Los Angeles 27
Ottawa 26
Cosenza 23
Des Moines 23
Cambridge 21
Ogden 20
Tokyo 19
Falkenstein 18
Guangzhou 18
Catanzaro 14
Rome 14
Ann Arbor 13
Biên Hòa 12
Wilmington 12
Catania 11
Florence 11
Izmir 11
Pune 11
Da Nang 10
West Jordan 10
Brno 9
Redwood City 9
Rio de Janeiro 9
Council Bluffs 8
Guayaquil 8
Inglewood 8
Milan 8
Quito 8
Seattle 8
Tianjin 8
Haiphong 7
Lamezia Terme 7
London 7
Montreal 7
Munich 7
Santa Clara 7
Thái Bình 7
Toronto 7
Baghdad 6
Belo Horizonte 6
Boston 6
Cape Town 6
Chicago 6
Guardavalle 6
Phoenix 6
Porto Alegre 6
San Francisco 6
Washington 6
Wuhan 6
Afyonkarahisar 5
Amsterdam 5
Bogotá 5
Brussels 5
Goiânia 5
Hải Dương 5
Mexico City 5
Nuremberg 5
Tashkent 5
Amman 4
Arezzo 4
Atlanta 4
Campo Calabro 4
Columbus 4
Denver 4
Dhaka 4
La Paz 4
Montevideo 4
Mumbai 4
Naples 4
Paris 4
Sorocaba 4
Strasbourg 4
The Dalles 4
Vibo Valentia 4
Warsaw 4
Anápolis 3
Totale 2.625
Nome #
Nanotechnology-based deliviery system of bergamot essential oil, method of preparation of the system and uses thereof. 195
Bergamot essential oil attenuates anxiety-like behaviour in rats 174
Aging brain: In search for better neurotherapeutics 172
Antinociceptive effect of inhalation of the essential oil of bergamot in mice 142
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Clinical Evidence and Possible Mechanisms 131
Ageing affects nociception in C57BL/6 mice. 131
Book of Abstracts – Aging Brain: In Search for Better Neurotherapeutics. 125
Book of Abstracts – Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation. 119
Opioids Resistance in Chronic Pain Management 115
Book of Abstracts - NEW TRENDS IN PAIN RESEARCH From Basic Research to Clinical Translation 109
Pharmacological basis for the treatment of Behavioural and Psychological Symptoms of Dementia (BPSDs) With Aromatherapy 108
Benefits and risks associated with cannabis and cannabis derivatives use 107
Spinal expression of autophagic markers following intraplantar formalin injection 104
Aging Brain: In Search of Better Neurotherapeutics 98
Characterization of alpha2-delta1 expression and response to chronic treatment with gabapentin in a mouse model of neuropathic pain. 98
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics 95
Innovazione farmacoterapeutica necessaria nella gestione dei behavioral and psychological symptoms nella demenza. 93
Role of mGlu-5 and mGlu2/3 receptors in behavioural effects of bergamot essential oil 88
The need for better access to pain treatment: learning from drug consumption trends in the USA 87
Anxiolytic-like/relaxant effects of BEO are useful to manage anxiety and agitation symptoms observed in patients with dementia 86
Involvment of metabotropic glutamate receptors in behavioural effects of bergamot essential oil 85
Characterisation of pain sensitivity in ageing mice 84
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia 83
Pain assessment for better pharmacological treatment of pain and agitation in severe dementia: I-MOBID2 validation. 82
Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists 82
Gender differences in pain response to peripheral injury in mice. 82
Behavioral and psychological symptoms of dementia (BPSD): evidence on pharmacoutilization from a large sample in the real-world setting 82
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy 81
Characterization of mechanical and thermal nociception in ageing mice. 79
CANNABIS UPDATE 2.0 78
Pharmacoepidemiology evidence in favour of a reduced access to pain treatment in patients assuming acetylcholinesterase inhibitors and memantine in the provincial health district of Cosenza . 78
Current opportunities for drug repurposing in pain management: is there a role for autophagy modulation? 77
Trattamento dei pazienti affetti da demenza in un real-world setting della regione Calabria: gestione dei sintomi comportamentali e del dolore. 76
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety 75
Need for a clinical trial investigating efficacy and safety of oral spray nabiximols for pain and agitation treatment in severe dementia patients. 73
Validation of an international pain assessment tool to improve pharmacological treatment of pain and agitation in severe dementia. 72
Evidenze farmacoepidemiologiche a favore di un ridotto accesso alla cura del dolore in pazienti trattati con inibitori delle colinesterasi e memantina nel territorio dell’Azienda Sanitaria Provinciale di Cosenza. 72
New trends in pain research: From basic research to clinical translation 71
Translation of bergamot essential oil in clinical trial for control of behavioral and psychological symptoms of dementia (BPSD) 69
Eptinezumab for the treatment of migraine 69
TRANSLATION OF BERGAMOT ESSENTIAL OIL IN CLINICAL TRIAL FOR CONTROL OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA 68
Indagine farmacoepidemiologica sul trattamento antidolorifico dei pazienti affetti da demenza in Calabria. 64
Real-world evidence supports combination therapy with anti-CGRP mAbs and onabotulinumtoxinA for chronic migraine 62
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-like Behaviour in Female Rats 60
Neuropsychiatric symptoms of dementia: role of pain and essential oil of bergamot as a novel therapeutic. 57
Influence of aging on nociception in C57BL/6 mice. 56
Evidence from the real-world of limited access to pain treatment in a large sample of patients suffering from dementia. 56
Basi razionali per la traslazione clinica dell’olio essenziale di bergamotto. 55
Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study 54
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems 52
Neuropharmacology of behavioral disorders in dementia. 50
Pharmacoutilization data-driven AI-assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia 49
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography 48
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders 47
R&D of an essential oil in dementia: the case model of Bergamot 41
Dolore. 33
Targeting pain to control neuropsychiatric symptoms of dementia: the need for tailored clinical trials. 23
Neuropharmacology of the neuropsychiatric symptoms of dementia: possible targets for novel therapeutic approaches 7
Totale 4.809
Categoria #
all - tutte 31.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021106 0 0 0 0 0 13 5 28 5 34 0 21
2021/2022475 1 33 5 4 34 30 61 89 19 26 54 119
2022/2023665 68 76 35 88 52 63 21 105 65 20 46 26
2023/2024587 45 31 33 25 33 114 23 27 64 29 37 126
2024/2025946 67 130 40 55 67 85 39 46 147 31 94 145
2025/20261.616 299 183 208 252 603 71 0 0 0 0 0 0
Totale 4.809